Skip to main content

Table 1 Characteristics of 3575 subjects of the Doetinchem Cohort in round 2 and 3

From: Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome

  Round 2: 1993-1997 Round 3: 1998-2002
Age (yr) 46.5 (9.7) 51.5 (9.7)
Sex (% men) 47.8 47.8
Waist circumference (cm) 90.2 (11.1) 92.9 (11.4)
Increased waist circumference (%)a 31.3 40.3
Glucose levels (mmol/L)b 5.3 (1.3) 5.4 (1.5)
Diabetic medication (%) 0.8 2.3
Hyperglycemia (%)a 28.8 33.6
HDL-cholesterol (mmol/L) 1.38 (0.38) 1.37 (0.39)
Low HDL-cholesterol (%)a 25.4 29.0
Diastolic Blood Pressure (mm Hg) 79.9 (10.6) 81.4 (10.7)
Systolic Blood Pressure (mm Hg) 125.1 (16.4) 129.3 (18.01)
Hypertension (%)a 50.8 58.5
Blood Pressure lowering medication (%) 6.5 11.0
MetS-score (number of features) 1.34 (1.1) 1.61 (1.1)
Metabolic syndrome prevalence (%) 14.9 22.7
  1. Data are presented as means (standard deviation) or %
  2. aAbdominal obesity, hyperglycemia, low HDL, hypertension and MetS are defined according to the criteria of AHA-NHLBI (2005). Abdominal obesity: ♂ ≥ 102 cm; ♀ ≥ 88 cm; Low HDL: ♂ < 1.0; ♀ < 1.3 mmol/L; hypertension: ≥ 130/85 mm Hg or hypertensive medicine; Hyperglycemia ≥ 5.6 (mmol/L) or glucose lowering medication; MetS is defined as having 3 MetS features measured in Doetinchem Cohort
  3. bNon-fasting values